ClinicalTrials.Veeva

Menu

An Investigation of the Dose-dependent Vascualr Effects of (-)-Epicatechin in Healthy Men

University of Reading logo

University of Reading

Status and phase

Completed
Early Phase 1

Conditions

Vasodilation

Treatments

Dietary Supplement: Epicatechin 1.0 mg/kg
Dietary Supplement: Epicatechin 0.1 mg/kg
Dietary Supplement: Water
Dietary Supplement: Epicatechin 0.5 mg/kg

Study type

Interventional

Funder types

Other

Identifiers

NCT02292342
EpicatechinStudy

Details and patient eligibility

About

Aim: To investigate the dose-dependent vascular effect (primarily using FMD) of 3 low-level doses of pure (-)-epicatechin ≤ 1 mg/kg BW (0.1, 0.5 & 1.0 mg/kg BW) in healthy men.

Enrollment

21 patients

Sex

Male

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Body Mass Index 20-27.5 kg/m2
  • Normal blood pressure at screening (< 150/90)
  • Non-smoker
  • Non-vegetarian
  • 'Normal - low' chocolate consumer (<2 potions per week)
  • 'Normal - low' coffee/ tea drinker (<3 cups per day)
  • Regular exercise routine
  • Signed consent form

Exclusion criteria

  • Haemoglobin (anaemia marker) < 125 g/l
  • Gamma GT (liver enzymes) > 80 IU/l
  • Cholesterol > 6.5 mmol/l
  • Suffered a myocardial infarction or stroke in the last 12 months
  • Suffers from any cardiovascular or metabolic disorders (e.g. diabetes or any other endocrine or liver diseases)
  • Suffers from any blood-clotting disorder, and/or takes supporting medication
  • Any dietary restrictions or on a weight reducing diet
  • On any lipid-modifying or blood pressure lowering medication
  • Consuming any specific vitamin/ herbal supplements or fish oils

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

21 participants in 4 patient groups, including a placebo group

0.1 mg/ kg BW pure (-)-epicatechin
Active Comparator group
Description:
0.1 mg/ kg BW pure (-)-epicatechin (according to volunteer) dissolved in 3 ml/kg BW of water.
Treatment:
Dietary Supplement: Epicatechin 1.0 mg/kg
Dietary Supplement: Water
Dietary Supplement: Epicatechin 0.1 mg/kg
Dietary Supplement: Epicatechin 0.5 mg/kg
0.5 mg/ kg BW pure (-)-epicatechin
Active Comparator group
Description:
0.5 mg/ kg BW pure (-)-epicatechin (according to volunteer) dissolved in 3 ml/kg BW of water.
Treatment:
Dietary Supplement: Epicatechin 1.0 mg/kg
Dietary Supplement: Water
Dietary Supplement: Epicatechin 0.1 mg/kg
Dietary Supplement: Epicatechin 0.5 mg/kg
1.0 mg/ kg BW pure (-)-epicatechin
Active Comparator group
Description:
1.0 mg/ kg BW pure (-)-epicatechin (according to volunteer) dissolved in 3 ml/kg BW of water.
Treatment:
Dietary Supplement: Epicatechin 1.0 mg/kg
Dietary Supplement: Water
Dietary Supplement: Epicatechin 0.1 mg/kg
Dietary Supplement: Epicatechin 0.5 mg/kg
0.0 mg/ kg BW pure (-)-epicatechin
Placebo Comparator group
Description:
Water only (3 ml/kg BW)
Treatment:
Dietary Supplement: Epicatechin 1.0 mg/kg
Dietary Supplement: Water
Dietary Supplement: Epicatechin 0.1 mg/kg
Dietary Supplement: Epicatechin 0.5 mg/kg

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems